From Our Writers

A licensed cannabis cultivator in Western Massachusetts is suing a neighboring produce farm, alleging that repeated instances of “pesticide overspray” ruined the neighboring cannabis company’s crops for years, amounting to $17 million in damages.

A Florida proposal would legalize limited cannabis home grows for medical cannabis patients; the measure caps the number of plants per household at two, regardless of how many patients live there.

Oklahoma Sen. James Lankford (R) has introduced legislation to prohibit cannabis operators from deducting business expenses from their taxes, even if cannabis were to be federally rescheduled under federal law.

A Maine legislative working group has recommended setting an age requirement of 21 for intoxicating hemp products in the state and adopting THC caps on hemp beverages.

More than 60% of Texas residents support legalizing adult-use cannabis, according to a recent poll. Support was even higher for cannabis decriminalization (69%) and medical legalization (79%).

A Tennessee proposal seeks to enact a statewide ban on products that contain smokable hemp flower.

Illinois cannabis dispensaries exceeded $2 billion in combined adult-use and medical cannabis sales last year, a new annual sales record for the state.

Arkansas medical cannabis retailers sold more products in 2024 than in the previous year but due to a lowering of prices, the industry’s total revenue dropped.

Lawmakers in two Hawaii House committees have advanced a bill to legalize cannabis and establish a regulated adult-use marketplace.

Pennsylvania Gov. Josh Shapiro (D) included the legalization of adult-use cannabis in his 2025-2026 budget proposal.

A new proposal in the Tennessee Legislature seeks to legalize cannabis for adults aged 21+, set a 15% excise tax on sales, and allow for the home cultivation of up to 12 plants.

Both chambers of the Virginia Legislature have passed bills this session to legalize adult-use cannabis sales. The governor, however, has said he will veto any legislation containing regulations for a cannabis marketplace — as he did last year.

Cannabis regulators in Massachusetts warned that some products sold in the state may have exceeded state-mandated levels of yeast, mold, and coliforms.

An Ohio proposal seeks to change the state’s adult-use cannabis policy, including reducing the amount of cannabis that can be grown at home, lowering the THC caps on cannabis concentrate products, raising the excise tax on the industry from 10% to 15%, and redirecting the state’s cannabis tax revenues.

Missouri courts have expunged more than 140,000 cannabis criminal cases under the state’s 2022 constitutional amendment to legalize adult-use cannabis.

The Tacoma, Washington City Council has unanimously passed a resolution to make prosecutions for entheogenic psychedelics the lowest priority for law enforcement.

Robert F. Kennedy Jr., the president’s nominee to lead the U.S. Department of Health and Human Services, said last week that if he is confirmed to the role, he would defer to the DEA on the issue of cannabis rescheduling.

Cannabis prices in Oregon are at an all-time low as the state continues to set new cannabis harvest records each year.

Kentucky officials have awarded the state’s first medical cannabis patient IDs, with about 2,200 applications approved.

A Maine proposal would require medical cannabis products to undergo rigorous testing for potency and contaminants, like in the state’s adult-use system.

New legislation introduced in Hawaii seeks to legalize adult-use cannabis and establish the Hawaii Cannabis and Hemp Office, which would oversee the state’s medical cannabis and hemp businesses alongside its future adult-use industry.

Officials with the New Mexico Cannabis Control Division are pushing elected officials to pass legislation creating a task force under the agency dedicated to stamping out illicit cannabis activity.

Indiana House Republicans have rejected a proposal to remove cannabis as a Schedule 1 drug under state law.

A class action lawsuit in Illinois claims that some state-licensed cannabis companies mislabeled cannabis-infused products as concentrates so they could exceed the legal THC limit for certain products.